EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease

Fnu Alnoor, Nicholas C Spies, Jyoti Kumar, Peyman Samghabadi, Oscar Silva, Matt X Luo iD, Karen M Chisholm iD, Jingjing Zhang, Alexandra Rangel, David Ng iD, Peng Li iD, Robert S Ohgami iD

American Journal of Hematology · 2025-11 · 100 (11) · 2064-2073

DOI: 10.1002/ajh.70039 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Hematology, online erschienen am 21.08.2025. Verfasst von Fnu Alnoor und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Castleman Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recordati Rare Diseases, Department of Pathology at the University of Utah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic multicentric Castleman disease (iMCD) is a rare cytokine‐driven disorder characterized by systemic inflammation, organ dysfunction, and altered lymph node microscopic architecture. Over the past decade, diagnostic criteria have evolved significantly, integrating clinical, histopathological, and molecular biomarker advancements. Key drivers of iMCD pathogenesis, such as interleukin‐6 dysregulation and other dysfunctional cytokine signaling, have been identified and led to the development of targeted therapies like siltuximab and tocilizumab. Histopathologic refinements have highlighted distinct subtypes, such as hypervascular, plasmacytic, and mixed histologic patterns, while molecular discoveries have unveiled potential paraneoplastic and clonal processes. Emerging technologies, including single‐cell sequencing, spatial transcriptomics, and digital pathology, offer promise in refining diagnostic precision and advancing personalized medicine. This review synthesizes historical frameworks, recent breakthroughs, and future directions in iMCD diagnostics, emphasizing the importance of multidisciplinary approaches for improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Castleman DiseaseHumansInterleukin-6Antibodies, Monoclonal, HumanizedBiomarkersAntibodies, Monoclonal

Stichwörter der Autor:innen

Castleman diseaseIgG4‐related diseasefibroblastic reticular cellsfollicular dendritic cellsidiopathic multicentric Castleman diseaseinterleukin‐6

Substanzen

siltuximabtocilizumabInterleukin-6Antibodies, Monoclonal, HumanizedBiomarkersAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • ARUP Laboratories, Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
  • Division of Pathology, Department of Diagnostic Medicine, The University of Texas at Austin, Austin, Texas, USA.
  • Department of Pathology, University of California, San Francisco, California, USA.
  • Department of Pathology, Stanford University, Stanford, California, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Matt X Luo, Karen M Chisholm, David Ng, Peng Li, Robert S Ohgami

Förderung

  • Recordati Rare Diseases
  • Department of Pathology at the University of Utah

Zitieren

APA

Alnoor, F., Spies, N. C., Kumar, J., Samghabadi, P., Silva, O., Luo, M. X., Chisholm, K. M., Zhang, J., Rangel, A., Ng, D., Li, P., & Ohgami, R. S. (2025). The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease. American Journal of Hematology, 100(11), 2064-2073. https://doi.org/10.1002/ajh.70039

Vancouver

Alnoor F, Spies NC, Kumar J, Samghabadi P, Silva O, Luo MX, et al. The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease. American Journal of Hematology. 2025;100(11):2064-2073. doi:10.1002/ajh.70039

BibTeX
@article{Alnoor2025,
  author = {Alnoor, Fnu and Spies, Nicholas C and Kumar, Jyoti and Samghabadi, Peyman and Silva, Oscar and Luo, Matt X and Chisholm, Karen M and Zhang, Jingjing and Rangel, Alexandra and Ng, David and Li, Peng and Ohgami, Robert S},
  title = {The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease},
  journal = {American Journal of Hematology},
  year = {2025},
  volume = {100},
  number = {11},
  pages = {2064--2073},
  doi = {10.1002/ajh.70039}
}
Kostenlos starten →